🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gillian Gresham

Cedars-Sinai Medical Center

ORCID: 0000-0001-7142-1230
MathematicsMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma”.

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-19401-3
N/A
0.587DataRank · unranked
10 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

JNCI Cancer Spectrum(2025)10.1093/jncics/pkaf032
N/A
0.208DataRank · unranked
3 citations

Sungjin Kim, N. Lynn Henry, Ron D. Hays, Vinícius F. Calsavara, Michael Luu +11 more

Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient‐reported outcomes in pancreatic cancer cachexia

Journal of Cachexia Sarcopenia and Muscle(2021)10.1002/jcsm.12799
N/A
0DataRank · unranked
24 citations

Veronica Placencio-Hickok, Marie Lauzon, Tyra Nguyen, Haesoo Kim, Sejal Mehta +9 more

Graphical representations of patient tolerability data: Recommendations from the National Cancer Institute (NCI) Cancer Moonshot Standardization Working Group.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18612
N/A
0DataRank · unranked
4 citations

Gina L. Mazza, Blake Langlais, Bellinda L. King‐Kallimanis, Lauren J. Rogak, Patient Tolerability Consortia Standardization Working Group +1 more

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

BMC Medical Research Methodology(2021)10.1186/s12874-021-01368-w
N/A
0DataRank · unranked
0 citations

Gillian Gresham, Sungjin Kim, Michael Luu, N. Lynn Henry, Mourad Tighiouart +4 more

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

npj Breast Cancer(2022)10.1038/s41523-022-00489-9
N/A
0DataRank · unranked
9 citations

Sungjin Kim, Ron D. Hays, Márcio A. Diniz, Mourad Tighiouart, Gillian Gresham +6 more

Ethnic and Racial Inequities in Cancer Screening During the COVID-19 Pandemic: a multi-site observational study in the United States

International Journal of Cancer Care and Delivery(2022)10.53876/001c.37412
N/A
0DataRank · unranked
3 citations

Hala T. Borno, Katarina Wang, Mark J. Pletcher, Gillian Gresham, Alison J. Canchola +11 more

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-23619-6
N/A
0DataRank · unranked
1 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

The growing implications of obesity for prostate cancer risk and mortality: where do we go from here?

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad140
N/A
0DataRank · unranked
7 citations

Stephen J. Freedland, Gillian Gresham, James P. Daniels

Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

Cancer Prevention Research(2023)10.1158/1940-6207.capr-23-0216
N/A
0DataRank · unranked
4 citations

N. Lynn Henry, Ron D. Hays, Sungjin Kim, Michael Luu, Márcio A. Diniz +7 more

DIET2TREAT: A randomized, multi-center, phase 2 trial of a ketogenic diet vs standard dietary guidance in combination with standard-of-care treatment for patients with newly diagnosed glioblastoma.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps2103
N/A
0DataRank · unranked
1 citations

Gillian Gresham, Nicholas Butowski, Katherine B. Peters, Akanksha Sharma, Ekokobe Fonkem +10 more

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database

The Oncologist(2025)10.1093/oncolo/oyaf007
N/A
0DataRank · unranked
7 citations

Edik M. Blais, John Davelaar, Matthew Ebia, Angela Minasyan, Nima Nikravesh +13 more

Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa028
N/A
0DataRank · unranked
40 citations

Márcio A. Diniz, Zahra S. Razaee, Michael Luu, Sungjin Kim, Ron D. Hays +6 more

Analyses of adverse events and patient‐reported outcomes with the toxicity index in cancer clinical trials

Cancer(2025)10.1002/cncr.70086
N/A
0DataRank · unranked
1 citations

N. Lynn Henry, Hanna Bandos, Vinícius F. Calsavara, Reena S. Cecchini, Márcio A. Diniz +8 more

A prospective trial of elemental enteral feeding in patients with pancreatic cancer cachexia (PANCAX-1).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.726
N/A
0DataRank · unranked
2 citations

Gillian Gresham, Haesoo Kim, Michelle Guan, Jar-Yee Liu, Brian Minton +6 more